LISA NESLINE: Open Payments
NPI 1225792757 · AKRON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,146 in 55 payments from 15 companies in 2025. Trend: 2023 $1,451 · 2024 $1,323 · 2025 $1,146
Food & beverage: $1,146
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $347 |
| QOL Medical, LLC | 7 | $143 |
| Ipsen Biopharmaceuticals, Inc | 4 | $88 |
| Aimmune Therapeutics, Inc. | 4 | $82 |
| VIVUS LLC | 4 | $75 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $74 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $71 |
| Janssen Biotech, Inc. | 3 | $62 |
| Celltrion USA Inc. | 2 | $43 |
| Phathom Pharmaceuticals, Inc. | 3 | $42 |
Products named: RINVOQ, Sucraid, IQIRVO, ZENPEP, QSYMIA, ENTYVIO, XIFAXAN, LINZESS.
Industry payments across OH — which companies pay providers there.
